2201 |
METHARAN N |
BETAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V, NEOMYCINE SULFATE BP 0.5 %W/V,THIOMERSAL BP 0.005 % W/V |
SOLUTION |
BOTTLE |
EYE: SHORT TERM TREATMENT OF STEROID RESPONSIVE INFLAMMATORY, EAR: OTITIS EXTERNA OR OTHER STEROID RESPONSIVE, NOSE: STEROID RESPONSIVE INFLAMMATORY CONDITIONS WHERE PROPHYLACTIC ANTIBIOTIC TREATMENT IS ALSO REQUIRED |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
04 I 4672/19 |
06-DEC-2022 |
05-DEC-2025 |
View |
2202 |
MFLOX |
MOXIFLOXACIN HYDROCHLORIDE BP EQ.TO MOXIFLOXACIN 0.5 % W/V |
EYE DROPS |
BOTTLE |
TOPICAL TREATMENT OF PURULENT BACTERIAL CONJUNCTIVITIS, CAUSED BY MOXIFLOXACIN SUSCEPTIBLE STRAINS, |
NULL |
POUNSAB PHARMA CO.,LTD |
AUROLAB |
INDIA |
CERTIFICATE RELEASED |
10 I 5610/23 |
09-Oct-2023 |
08-Oct-2026 |
View |
2203 |
MFLOX-DM |
MOXIFLOXACIN HYDROCHLORIDE BP EQ.TO MOXIFLOXACIN 0.5 % W/V, DEXAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V |
EYE DROPS |
BOTTLE |
PREVENTION AND TREATMENT OF INFLAMMATION AND PREVENTION OF INFECTION ASSOCIATED WITH CATARACT SURGERY IN ADULTS AND CHILDREN AGED 2 YEARS AND OLDER |
NULL |
POUNSAB PHARMA CO.,LTD |
AUROLAB |
INDIA |
CERTIFICATE RELEASED |
10 I 5611/23 |
09-Oct-2023 |
08-Oct-2026 |
View |
2204 |
MIZOLE |
CLOTRIMAZOLE 500 MG |
TABLET |
BLISTERPACK |
FOR THE TREATMENT OF VAGINAL CANDIDIASIS, TRICHOMONIASIS, CHRONIC RECURRENT MYCOSIS, VAGINITIS DUE TO FUNGI, INFECTIONS LEUCORRHOEA, VAGINAL MYCOSIS DURING PREGNANCY, PROPHYLACTIC AGAINST NEONATAL THRUSH AS PRENATAL THERAPY, DYSPAREUNIA. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4184/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
2205 |
MORCET TABLETS 10 MG |
ESCITALOPRAM OXALATE 12.78 MG EQ.TO ESCITALOPRAM 10 MG |
TABLET |
ALU-PVC BLISTER |
INDICATED FOR SYMPTOMATIC RELIEF OF MAJOR DEPRESSIVE DISORDER, ANXIETY CAUSING CLINICALLY SIGNIFICANT DISTRESS IN PATIENTS WITH GENERALISED ANXIETY DISORDER, OBSESSIVE-COMPULSIVE DISORDER |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5509/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
2206 |
MORCET TABLETS 20 MG |
ESCITALOPRAM OXLATE 25.54 MG EQ.TO ESCITALOPRAM 20 MG |
TABLETS |
ALU-PVC BLISTER |
FOR SYMPTOMATIC RELIEF OF MAJOR DEPRESSIVE, ANXIETY CAUSING CLINICALLY SIGNIFICANT DISTRESS IN PATIENTS WITH GENERALIZED ANXIETY DISORDER, OBSESSIVE-COMPULSIVE DISORDER |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 5765/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
2207 |
MYOSOFT |
THIOCOLCHICOSIDE 4 MG |
CAPSULE |
BLISTERPACK |
TREATMENT OF THE PAINFUL MUSCULAR CONTRACTURES IN ACUTE AND CHRONIC RHEUMATOLOGIC AND ORTHOPEDIC DISEASES (LUMBAGO, SCIATICA, CERVICOBRACHIAL PAIN. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4205/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
2208 |
OMIPIN |
OMEPRAZOLE SODIUM BP EQ.TO OMEPRAZOLE 40 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
FOR SHORT TERM TREATMENT OF DUODENAL ULCER, GASTRIC ULCER, REFLUX OESOPHAGITIS, ZOLLINGER-ELLISON SYDROME WHEN ORAL THERAPY IS REGARDED INAPPROPRIATE OR CONTRA-INDICATED, FOR UP TO 5 DAYS |
NULL |
POUNSAB PHARMA CO.,LTD |
BRAWN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
04 I 4674/19 |
06-DEC-2022 |
05-DEC-2025 |
View |
2209 |
ONLEZOLE |
FLUCONAZOLE USP 150 MG |
CAPSULE |
BLISTERPACK |
INDICATED FOR THE TREATMENT AND PROPHYLAXIS OF FUNGAL INFECTIONS WHERE OTHER ANTIFUNGALS HAVE FAILED OR ARE NOT TOLERATED |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4193/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
2210 |
PAAR 250 |
PARACETAMOL BP 250 MG/ 5 ML |
ORAL SUSPENSION |
BOTTLE |
FOR THE TREATMENT OF MILD TO MODERATE PAIN, INCLUDING HEADACHE, MIGRAINE, NEURALGIA, TOOTHACHE, SORE THROAT, ACHES AND PAINS, FOR THE REDUCTION OF FEVER AND TO BE USED AS AN ADJUNCTIVE TREATMENT TO RELIEVE SYMPTOMS OF COLD AND FLU. |
NULL |
POUNSAB PHARMA CO.,LTD |
BAROQUE PHARMACEUTICALS PVT LTD. |
INDIA |
CERTIFICATE RELEASED |
09 I 4204/16 |
07-JUL-2025 |
06-JUL-2030 |
View |